Core Laboratories Q3 2023 Adj EPS $0.22, Inline, Sales $125.34M Miss $129.97M Estimate
Portfolio Pulse from vinayak@benzinga.com
Core Laboratories (NYSE:CLB) reported Q3 2023 earnings of $0.22 per share, in line with analyst consensus. This is a 22.22% increase from the same period last year. However, the company's quarterly sales of $125.34 million missed the analyst consensus estimate of $129.97 million by 3.56%, marking a 0.49% decrease from last year.
November 01, 2023 | 9:47 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Core Laboratories' Q3 2023 earnings met expectations but sales missed estimates, which could potentially impact the company's stock negatively in the short term.
While Core Laboratories' earnings met expectations, the company's sales missed estimates by 3.56%. This could potentially lead to a negative sentiment among investors, which could impact the company's stock negatively in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100